Literature DB >> 29889678

Nivolumab-Associated Guillain-Barre Syndrome in a Patient With Non-Small-Cell Lung Cancer.

Bicky Thapa1, Sidra Khalid1, Roya Vakili2, Jennifer Ui3, Seema Misbah4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29889678     DOI: 10.1097/MJT.0000000000000771

Source DB:  PubMed          Journal:  Am J Ther        ISSN: 1075-2765            Impact factor:   2.688


× No keyword cloud information.
  1 in total

1.  Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature.

Authors:  Nicholas Gravbrot; Katalin Scherer; Srinath Sundararajan
Journal:  Case Rep Oncol Med       Date:  2019-11-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.